Advertisement

Index by author

May 01, 1990; Volume 18,Issue 3

A

  1. Aoyama, T

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  2. Apseloff, G

    1. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
      G Apseloff, D R Shepard, M A Chambers, S Nawoot, D C Mays and N Gerber
      Drug Metabolism and Disposition May 1990, 18 (3) 298-303;

  3. Arnaud, M J

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

  4. Aungst, B J

    1. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
      M A Hussain, S M Rowe, A B Shenvi and B J Aungst
      Drug Metabolism and Disposition May 1990, 18 (3) 288-291;

B

  1. Benet, L Z

    1. Nitroglycerin metabolism in subcellular fractions of rabbit liver. Dose dependency of glyceryl dinitrate formation and possible involvement of multiple isozymes of glutathione S-transferases.
      D T Lau and L Z Benet
      Drug Metabolism and Disposition May 1990, 18 (3) 292-297;

  2. Bevan, R

    1. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
      E M Cretton, D V Waterhous, R Bevan and J P Sommadossi
      Drug Metabolism and Disposition May 1990, 18 (3) 369-372;

  3. Bezek, S

    1. The effect of primary metabolites of the xanthine-related nootropic drug ethimizol on its hepatic extraction ratio.
      M Kukan, S Bezek, T Trnovec and L B Piotrovskiy
      Drug Metabolism and Disposition May 1990, 18 (3) 383-385;

  4. Bienvenu, T

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

  5. Billings, R E

    1. Bromobenzene metabolism in vivo and in vitro. The mechanism of 4-bromocatechol formation.
      N E Miller, D Thomas and R E Billings
      Drug Metabolism and Disposition May 1990, 18 (3) 304-308;

  6. Birkett, D J

    1. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
      M E Veronese, M E McManus, P Laupattarakasem, J O Miners and D J Birkett
      Drug Metabolism and Disposition May 1990, 18 (3) 356-361;

  7. Bredberg, U

    1. Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat.
      U Bredberg and L Paalzow
      Drug Metabolism and Disposition May 1990, 18 (3) 338-343;

  8. Broly, F

    1. Mexiletine metabolism in vitro by human liver.
      F Broly, C Libersa and M Lhermitte
      Drug Metabolism and Disposition May 1990, 18 (3) 362-368;

  9. Burnette, T C

    1. Tissue distribution and metabolic disposition of zidovudine in rats.
      P de Miranda, T C Burnette and S S Good
      Drug Metabolism and Disposition May 1990, 18 (3) 315-320;

C

  1. Chambers, M A

    1. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
      G Apseloff, D R Shepard, M A Chambers, S Nawoot, D C Mays and N Gerber
      Drug Metabolism and Disposition May 1990, 18 (3) 298-303;

  2. Chen, D

    1. Ethyl carbamate metabolism: in vivo inhibitors and in vitro enzymatic systems.
      T Yamamoto, W M Pierce, H E Hurst, D Chen and W J Waddell
      Drug Metabolism and Disposition May 1990, 18 (3) 276-280;

  3. Cretton, E M

    1. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
      E M Cretton, D V Waterhous, R Bevan and J P Sommadossi
      Drug Metabolism and Disposition May 1990, 18 (3) 369-372;

  4. Crouch, R

    1. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
      S S Good, C S Koble, R Crouch, R L Johnson, J L Rideout and P de Miranda
      Drug Metabolism and Disposition May 1990, 18 (3) 321-326;

D

  1. d'Athis, P

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

  2. de Miranda, P

    1. Tissue distribution and metabolic disposition of zidovudine in rats.
      P de Miranda, T C Burnette and S S Good
      Drug Metabolism and Disposition May 1990, 18 (3) 315-320;
    2. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
      S S Good, C S Koble, R Crouch, R L Johnson, J L Rideout and P de Miranda
      Drug Metabolism and Disposition May 1990, 18 (3) 321-326;

  3. Dickinson, R G

    1. The role of sulfate conjugation in the elimination kinetics of diflunisal in the rat.
      R K Verbeeck and R G Dickinson
      Drug Metabolism and Disposition May 1990, 18 (3) 267-269;

F

  1. Feng, P C

    1. Metabolism of alachlor by rat and mouse liver and nasal turbinate tissues.
      P C Feng, A G Wilson, R H McClanahan, J E Patanella and S J Wratten
      Drug Metabolism and Disposition May 1990, 18 (3) 373-377;

  2. Fleckenstein, L

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

G

  1. Geary, R S

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

  2. Gelboin, H V

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  3. Gerber, N

    1. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
      G Apseloff, D R Shepard, M A Chambers, S Nawoot, D C Mays and N Gerber
      Drug Metabolism and Disposition May 1990, 18 (3) 298-303;

  4. Gillette, J

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  5. Gonzalez, F J

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  6. Good, S S

    1. Tissue distribution and metabolic disposition of zidovudine in rats.
      P de Miranda, T C Burnette and S S Good
      Drug Metabolism and Disposition May 1990, 18 (3) 315-320;
    2. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
      S S Good, C S Koble, R Crouch, R L Johnson, J L Rideout and P de Miranda
      Drug Metabolism and Disposition May 1990, 18 (3) 321-326;

H

  1. Harvey, D J

    1. Oxidative cleavage of the pentyl side-chain of cannabinoids. Identification of new biotransformation pathways in the metabolism of 4'-hydroxy-delta-9-tetrahydrocannabinol in the mouse.
      D J Harvey
      Drug Metabolism and Disposition May 1990, 18 (3) 350-355;

  2. Hasinoff, B B

    1. The hydrolysis activation of the doxorubicin cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).
      B B Hasinoff
      Drug Metabolism and Disposition May 1990, 18 (3) 344-349;

  3. Huelle, B K

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

  4. Hurst, H E

    1. Ethyl carbamate metabolism: in vivo inhibitors and in vitro enzymatic systems.
      T Yamamoto, W M Pierce, H E Hurst, D Chen and W J Waddell
      Drug Metabolism and Disposition May 1990, 18 (3) 276-280;

  5. Hussain, M A

    1. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
      M A Hussain, S M Rowe, A B Shenvi and B J Aungst
      Drug Metabolism and Disposition May 1990, 18 (3) 288-291;

J

  1. Johnson, R L

    1. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
      S S Good, C S Koble, R Crouch, R L Johnson, J L Rideout and P de Miranda
      Drug Metabolism and Disposition May 1990, 18 (3) 321-326;

K

  1. Koble, C S

    1. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
      S S Good, C S Koble, R Crouch, R L Johnson, J L Rideout and P de Miranda
      Drug Metabolism and Disposition May 1990, 18 (3) 321-326;

  2. Korzekwa, K

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  3. Kukan, M

    1. The effect of primary metabolites of the xanthine-related nootropic drug ethimizol on its hepatic extraction ratio.
      M Kukan, S Bezek, T Trnovec and L B Piotrovskiy
      Drug Metabolism and Disposition May 1990, 18 (3) 383-385;

L

  1. Lau, D T

    1. Nitroglycerin metabolism in subcellular fractions of rabbit liver. Dose dependency of glyceryl dinitrate formation and possible involvement of multiple isozymes of glutathione S-transferases.
      D T Lau and L Z Benet
      Drug Metabolism and Disposition May 1990, 18 (3) 292-297;

  2. Laupattarakasem, P

    1. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
      M E Veronese, M E McManus, P Laupattarakasem, J O Miners and D J Birkett
      Drug Metabolism and Disposition May 1990, 18 (3) 356-361;

  3. Lhermitte, M

    1. Mexiletine metabolism in vitro by human liver.
      F Broly, C Libersa and M Lhermitte
      Drug Metabolism and Disposition May 1990, 18 (3) 362-368;

  4. Libersa, C

    1. Mexiletine metabolism in vitro by human liver.
      F Broly, C Libersa and M Lhermitte
      Drug Metabolism and Disposition May 1990, 18 (3) 362-368;

  5. Ludden, T M

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

M

  1. Mangold, D J

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

  2. Matsunaga, T

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  3. Mays, D C

    1. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
      G Apseloff, D R Shepard, M A Chambers, S Nawoot, D C Mays and N Gerber
      Drug Metabolism and Disposition May 1990, 18 (3) 298-303;

  4. McClanahan, R H

    1. Metabolism of alachlor by rat and mouse liver and nasal turbinate tissues.
      P C Feng, A G Wilson, R H McClanahan, J E Patanella and S J Wratten
      Drug Metabolism and Disposition May 1990, 18 (3) 373-377;

  5. McManus, M E

    1. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
      M E Veronese, M E McManus, P Laupattarakasem, J O Miners and D J Birkett
      Drug Metabolism and Disposition May 1990, 18 (3) 356-361;

  6. Miller, M A

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

  7. Miller, N E

    1. Bromobenzene metabolism in vivo and in vitro. The mechanism of 4-bromocatechol formation.
      N E Miller, D Thomas and R E Billings
      Drug Metabolism and Disposition May 1990, 18 (3) 304-308;

  8. Miners, J O

    1. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
      M E Veronese, M E McManus, P Laupattarakasem, J O Miners and D J Birkett
      Drug Metabolism and Disposition May 1990, 18 (3) 356-361;

  9. Mulder, G J

    1. The effect of hepatic blood flow on formation of metabolites.
      K S Pang and G J Mulder
      Drug Metabolism and Disposition May 1990, 18 (3) 270-275;

  10. Mutlib, A E

    1. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes.
      A E Mutlib and W L Nelson
      Drug Metabolism and Disposition May 1990, 18 (3) 309-314;
    2. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes.
      A E Mutlib and W L Nelson
      Drug Metabolism and Disposition May 1990, 18 (3) 331-337;

N

  1. Nagata, K

    1. cDNA-directed expression of rat P450s IIA1 and IIA2. Catalytic activities toward steroids and xenobiotics and comparison with the enzymes purified from liver.
      T Aoyama, K Korzekwa, T Matsunaga, K Nagata, J Gillette, H V Gelboin and F J Gonzalez
      Drug Metabolism and Disposition May 1990, 18 (3) 378-382;

  2. Nawoot, S

    1. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
      G Apseloff, D R Shepard, M A Chambers, S Nawoot, D C Mays and N Gerber
      Drug Metabolism and Disposition May 1990, 18 (3) 298-303;

  3. Nelson, W L

    1. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes.
      A E Mutlib and W L Nelson
      Drug Metabolism and Disposition May 1990, 18 (3) 309-314;
    2. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes.
      A E Mutlib and W L Nelson
      Drug Metabolism and Disposition May 1990, 18 (3) 331-337;

O

  1. Olive, G

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

P

  1. Paalzow, L

    1. Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat.
      U Bredberg and L Paalzow
      Drug Metabolism and Disposition May 1990, 18 (3) 338-343;

  2. Pang, K S

    1. The effect of hepatic blood flow on formation of metabolites.
      K S Pang and G J Mulder
      Drug Metabolism and Disposition May 1990, 18 (3) 270-275;

  3. Patanella, J E

    1. Metabolism of alachlor by rat and mouse liver and nasal turbinate tissues.
      P C Feng, A G Wilson, R H McClanahan, J E Patanella and S J Wratten
      Drug Metabolism and Disposition May 1990, 18 (3) 373-377;

  4. Pierce, W M

    1. Ethyl carbamate metabolism: in vivo inhibitors and in vitro enzymatic systems.
      T Yamamoto, W M Pierce, H E Hurst, D Chen and W J Waddell
      Drug Metabolism and Disposition May 1990, 18 (3) 276-280;

  5. Piotrovskiy, L B

    1. The effect of primary metabolites of the xanthine-related nootropic drug ethimizol on its hepatic extraction ratio.
      M Kukan, S Bezek, T Trnovec and L B Piotrovskiy
      Drug Metabolism and Disposition May 1990, 18 (3) 383-385;

  6. Pons, G

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

R

  1. Rey, E

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

  2. Richard, M O

    1. Effect of growth hormone on caffeine metabolism in hypophysectomized rats.
      T Bienvenu, G Pons, E Rey, M O Richard, P d'Athis, M J Arnaud and G Olive
      Drug Metabolism and Disposition May 1990, 18 (3) 327-330;

  3. Rideout, J L

    1. Isolation and characterization of an ether glucuronide of zidovudine, a major metabolite in monkeys and humans.
      S S Good, C S Koble, R Crouch, R L Johnson, J L Rideout and P de Miranda
      Drug Metabolism and Disposition May 1990, 18 (3) 321-326;

  4. Rowe, S M

    1. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
      M A Hussain, S M Rowe, A B Shenvi and B J Aungst
      Drug Metabolism and Disposition May 1990, 18 (3) 288-291;

S

  1. Sanchez-Barona, D O

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

  2. Shenvi, A B

    1. Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative.
      M A Hussain, S M Rowe, A B Shenvi and B J Aungst
      Drug Metabolism and Disposition May 1990, 18 (3) 288-291;

  3. Shepard, D R

    1. Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans.
      G Apseloff, D R Shepard, M A Chambers, S Nawoot, D C Mays and N Gerber
      Drug Metabolism and Disposition May 1990, 18 (3) 298-303;

  4. Sommadossi, J P

    1. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
      E M Cretton, D V Waterhous, R Bevan and J P Sommadossi
      Drug Metabolism and Disposition May 1990, 18 (3) 369-372;

  5. Swynnerton, N F

    1. Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
      D J Mangold, B K Huelle, M A Miller, R S Geary, D O Sanchez-Barona, N F Swynnerton, L Fleckenstein and T M Ludden
      Drug Metabolism and Disposition May 1990, 18 (3) 281-287;

T

  1. Thomas, D

    1. Bromobenzene metabolism in vivo and in vitro. The mechanism of 4-bromocatechol formation.
      N E Miller, D Thomas and R E Billings
      Drug Metabolism and Disposition May 1990, 18 (3) 304-308;

  2. Trnovec, T

    1. The effect of primary metabolites of the xanthine-related nootropic drug ethimizol on its hepatic extraction ratio.
      M Kukan, S Bezek, T Trnovec and L B Piotrovskiy
      Drug Metabolism and Disposition May 1990, 18 (3) 383-385;

V

  1. Verbeeck, R K

    1. The role of sulfate conjugation in the elimination kinetics of diflunisal in the rat.
      R K Verbeeck and R G Dickinson
      Drug Metabolism and Disposition May 1990, 18 (3) 267-269;

  2. Veronese, M E

    1. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
      M E Veronese, M E McManus, P Laupattarakasem, J O Miners and D J Birkett
      Drug Metabolism and Disposition May 1990, 18 (3) 356-361;

W

  1. Waddell, W J

    1. Ethyl carbamate metabolism: in vivo inhibitors and in vitro enzymatic systems.
      T Yamamoto, W M Pierce, H E Hurst, D Chen and W J Waddell
      Drug Metabolism and Disposition May 1990, 18 (3) 276-280;

  2. Waterhous, D V

    1. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
      E M Cretton, D V Waterhous, R Bevan and J P Sommadossi
      Drug Metabolism and Disposition May 1990, 18 (3) 369-372;

  3. Wilson, A G

    1. Metabolism of alachlor by rat and mouse liver and nasal turbinate tissues.
      P C Feng, A G Wilson, R H McClanahan, J E Patanella and S J Wratten
      Drug Metabolism and Disposition May 1990, 18 (3) 373-377;

  4. Wratten, S J

    1. Metabolism of alachlor by rat and mouse liver and nasal turbinate tissues.
      P C Feng, A G Wilson, R H McClanahan, J E Patanella and S J Wratten
      Drug Metabolism and Disposition May 1990, 18 (3) 373-377;

Y

  1. Yamamoto, T

    1. Ethyl carbamate metabolism: in vivo inhibitors and in vitro enzymatic systems.
      T Yamamoto, W M Pierce, H E Hurst, D Chen and W J Waddell
      Drug Metabolism and Disposition May 1990, 18 (3) 276-280;
Back to top

In this issue

Advertisement